These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17289081)

  • 1. A mathematical model of breast cancer development, local treatment and recurrence.
    Enderling H; Chaplain MA; Anderson AR; Vaidya JS
    J Theor Biol; 2007 May; 246(2):245-59. PubMed ID: 17289081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modelling of radiotherapy strategies for early breast cancer.
    Enderling H; Anderson AR; Chaplain MA; Munro AJ; Vaidya JS
    J Theor Biol; 2006 Jul; 241(1):158-71. PubMed ID: 16386275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic models of human cancer as a multistep process. Paradigm models of colorectal cancer, breast cancer, and chronic myelogenous and acute lymphoblastic leukaemia.
    Karakosta A; Golias Ch; Charalabopoulos A; Peschos D; Batistatou A; Charalabopoulos K
    J Exp Clin Cancer Res; 2005 Dec; 24(4):505-14. PubMed ID: 16471312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenesis by mutations in anti-oncogenes: a view.
    Den Otter W; Koten JW; Van der Vegt BJ; Beemer FA; Boxma OJ; Derkinderen DJ; De Graaf PW; Huber J; Lips CJ; Roholl PJ
    Anticancer Res; 1990; 10(2B):475-87. PubMed ID: 2190526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor suppressor genetics.
    Payne SR; Kemp CJ
    Carcinogenesis; 2005 Dec; 26(12):2031-45. PubMed ID: 16150895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the steps that lead to cancer: replicative telomere erosion, aneuploidy and an epigenetic maturation arrest of tissue stem cells.
    Stindl R
    Med Hypotheses; 2008; 71(1):126-40. PubMed ID: 18294777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression analysis of candidate breast tumour suppressor genes on chromosome 16q.
    van Wezel T; Lombaerts M; van Roon EH; Philippo K; Baelde HJ; Szuhai K; Cornelisse CJ; Cleton-Jansen AM
    Breast Cancer Res; 2005; 7(6):R998-1004. PubMed ID: 16280054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can chromosomal instability initiate tumorigenesis?
    Michor F; Iwasa Y; Vogelstein B; Lengauer C; Nowak MA
    Semin Cancer Biol; 2005 Feb; 15(1):43-9. PubMed ID: 15613287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 4-mutation model of carcinogenesis for tumour suppressor genes.
    Den Otter W; Koten JW
    Anticancer Res; 1999; 19(6A):4845-52. PubMed ID: 10697598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterozygous Aprt mouse model: detection and study of a broad range of autosomal somatic mutations in vivo.
    Vrieling H; Wijnhoven S; van Sloun P; Kool H; Giphart-Gassler M; van Zeeland A
    Environ Mol Mutagen; 1999; 34(2-3):84-9. PubMed ID: 10529730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Information dynamics in carcinogenesis and tumor growth.
    Gatenby RA; Frieden BR
    Mutat Res; 2004 Dec; 568(2):259-73. PubMed ID: 15542113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetics and genomics of cancer.
    Balmain A; Gray J; Ponder B
    Nat Genet; 2003 Mar; 33 Suppl():238-44. PubMed ID: 12610533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes.
    Melchor L; Benítez J
    Carcinogenesis; 2008 Aug; 29(8):1475-82. PubMed ID: 18596026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A genetic progression model of oral cancer: current evidence and clinical implications.
    Braakhuis BJ; Leemans CR; Brakenhoff RH
    J Oral Pathol Med; 2004 Jul; 33(6):317-22. PubMed ID: 15200478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of metastasis suppressor gene inactivation.
    Michor F; Iwasa Y
    J Theor Biol; 2006 Aug; 241(3):676-89. PubMed ID: 16497335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of FANCB and FANCN/PALB2 fanconi anemia genes in BRCA1/2-negative Spanish breast cancer families.
    García MJ; Fernández V; Osorio A; Barroso A; Llort G; Lázaro C; Blanco I; Caldés T; de la Hoya M; Ramón Y Cajal T; Alonso C; Tejada MI; San Román C; Robles-Díaz L; Urioste M; Benítez J
    Breast Cancer Res Treat; 2009 Feb; 113(3):545-51. PubMed ID: 18302019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence].
    Fodor J
    Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
    BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy after segmental resection of breast cancer with favorable prognostic features: 12-year follow-up results of a randomized trial.
    Holli K; Hietanen P; Saaristo R; Huhtala H; Hakama M; Joensuu H
    J Clin Oncol; 2009 Feb; 27(6):927-32. PubMed ID: 19114687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The preferred treatment for young women with breast cancer--mastectomy versus breast conservation.
    van Nes JG; van de Velde CJ
    Breast; 2006 Dec; 15 Suppl 2():S3-10. PubMed ID: 17382859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.